FeesSafety
Pluang+

Rio2 Limited joins MVIS Global Junior Gold Miners Index, boosting visibility and liquidity.

Market News
14 Sep 2026
Newsfile Corp
View Source
Bullish
Rio2 Limited joins MVIS Global Junior Gold Miners Index, boosting visibility and liquidity.

Rio2 Limited has been added to the MVIS Global Junior Gold Miners Index, effective September 18, 2026. This index tracks small-cap gold and silver mining companies and inclusion is expected to enhance Rio2's visibility among investors, improve trading liquidity, and increase exposure to global capital markets. Rio2 operates gold and copper mines in Chile and Peru with a strong commitment to environmental and social responsibility. This move could attract more investor interest and support Rio2's growth in the precious metals sector.

Rio2 Limited's inclusion in the MVIS Global Junior Gold Miners Index is noted here alongside Pluang's Basic Materials sector data. For readers following this sector, here is Pluang's market snapshot as of Sep 14, 2026 21:52 WIB: of 32 priced Basic Materials-sector US stocks tradable on Pluang, 2 rose and 30 fell today. Notable prices include SCCO at USD 186.79 with a 1-day change of -3.46%, VALE at USD 14.71 down 3.45%, and FCX at USD 68.63 down 3.43%.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
45 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App